跳至主要内容
临床试验/NCT04475211
NCT04475211已完成不适用

Predictors of Mortality at Day 28 of Patients Treated at Lille University Hospital for COVID-19

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 757 人开始时间: 2020年8月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
757
试验地点
1
主要终点
Number of patients "confirmed cases" of SARS-CoV-2 infection who died at D28 of inclusion

研究概览

简要总结

The Lille University Hospital developped a research objective common to all the services which took care of patients, "suspected patient", "possible case", "probable case" or "confirmed case" infected with SARS-CoV-2 by constituting a prospective and a retrospective observational cohort which allowed pooling and sharing the resources and data collected. In the next two years the prospective cohort will allow to continue inclusions in a standardized way mainly for the constitution of a negative control group (excluded cases), to collect biological samples which had not been collected in the retrospective cohort so that the pathophysiology of the COVID-19 will be better apprehended as for example the inflammatory response to the viral infection. Finally in case of a second epidemic wave in the Hauts De France, it seems essential to have a defined research protocol which had already received all the necessary authorizations to guarantee cutting-edge (or quality ) research in a center like the Lille University Hospital.The aim objective of this study is to identify predictive factors of mortality to day 28 infection to SARS-CoV-2 for patients under medical care for the COVID-19 in the Lille University Hospital thanks to the constitution of an epidemiological, clinical, biological, immunological, genetic, microbiological, anatomopathologic, radiological, therapeutic database and so record the results of functional exploration exams.

详细描述

This is a retrospective and prospective observational monocentric cohort study designed to identify predictors of mortality on day 28 in patients treated at the Lille University Hospital for COVID-19.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult "suspect patient", "possible case", "probable case" or "confirmed case" of an SARS-CoV-2 infection admitted to Lille University Hospital.

排除标准

  • Minor patient Patient under guardianship or curatorship Refusal to participate in the study Patient for whom the collection of genetic non-opposition or consent is impossible because of a language barrier with the patient himself or herself or with his or her trusted person or close family.
  • Patient for whom the collection of genetic non-opposition or consent is impossible because of his or her state of health at the time of inclusion in the study and for whom the trusted person or close family member opposes participation in the study.
  • Translated with www.DeepL.com/Translator (free version)

结局指标

主要结局

Number of patients "confirmed cases" of SARS-CoV-2 infection who died at D28 of inclusion

时间窗: At 28 days

Identify predictors of mortality at day 28 in patients treated at the Lille University Hospital for COVID-19

次要结局

  • Correlation between hospitalisation and all predictors for Covid-19(At inclusion( Day 0))
  • Correlation between overall survival at Day 28 and all predictors for Covid-19(At 28 day)
  • Correlation between risk factors measured at D0 for severe CoV-2 SARS infection and all predictors for Covid-19(At 28 day)
  • Biobanking for further analyses such as SARS-CoV2 studies(At 6 months)
  • Correlation between Infection characteristics of patients at inclusion and all predictors for Covid-19(At inclusion (day 0))
  • Correlation between evolution infection characteristics of patients during stay of hospitalisation and all predictors for Covid-19(At inclusion ( day 0) ,at day 1 , day3±1, Day 5±1, day 7±1, day 9±2, day14±2, day30±3, at months 3±7 days and at months6±7days or until death)
  • Positivity for Covid-19 patients performed and all predictors for Covid-19(At inclusion (day 0))
  • Cumulative incidence of at least one complication related to COVID 19(during hospitalization or during outpatient follow-up of "confirmed case" patients at Lille University Hospital (maximum observation period 6 months).)
  • Alteration of microbiota(At 6 months)
  • Cumulative incidence of the thrombosis complication related to COVID 19(during hospitalization or during outpatient follow-up of "confirmed case" patients at Lille University Hospital (maximum observation period 6 months).)
  • All type of co-infections(At 6 months)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验